Aroniadis Olga C, Brandt Lawrence J
Dr Aroniadis is a gastroenterology fellow at Montefiore Medical Center in the Bronx, New York. Dr Brandt is the emeritus chief of gastroenterology at Montefiore Medical Center and a professor of medicine and surgery at the Albert Einstein College of Medicine of Yeshiva University in the Bronx, New York.
Gastroenterol Hepatol (N Y). 2014 Apr;10(4):230-7.
Fecal microbiota transplantation (FMT) refers to the infusion of a fecal suspension from a healthy person into the gastrointestinal (GI) tract of another person to cure a specific disease. FMT is by no means a new therapeutic modality, although it was only relatively recently that stool was shown to be a biologically active, complex mixture of living organisms with great therapeutic potential for recurrent Clostridium difficile infection and perhaps other GI and non-GI disorders. The published revelations about the human microbiome are bringing the strength of science to clinical observation and enhancing the understanding of not only disease but also how much of a person's daily function and health depends on the microorganisms living in intimate relationship with each cell in the body.
粪便微生物群移植(FMT)是指将健康人的粪便悬液输注到另一人的胃肠道中以治疗特定疾病。尽管直到最近才发现粪便其实是一种具有生物活性的复杂生物体混合物,对复发性艰难梭菌感染以及其他可能的胃肠道和非胃肠道疾病具有巨大治疗潜力,但FMT绝不是一种新的治疗方式。已发表的关于人类微生物组的研究成果正将科学力量引入临床观察,不仅增进了对疾病的理解,还加深了对人体日常功能和健康在多大程度上依赖于与体内每个细胞密切共生的微生物的认识。